Fangzhou Inc. (HKG:6086)
Hong Kong · Delayed Price · Currency is HKD 1.250
-0.040 (-3.10%)
Apr 22, 2026, 4:08 PM HKT
Fangzhou Revenue
In the year 2025, Fangzhou had annual revenue of 3.53B CNY with 30.24% growth. Fangzhou had revenue of 2.03B in the half year ending December 31, 2025, with 77.78% growth.
Revenue
3.53B CNY
Revenue Growth
+30.24%
P/S Ratio
0.46
Revenue / Employee
7.14M CNY
Employees
494
Market Cap
1.79B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.53B | 818.79M | 30.24% |
| Dec 31, 2024 | 2.71B | 273.06M | 11.22% |
| Dec 31, 2023 | 2.43B | 230.01M | 10.43% |
| Dec 31, 2022 | 2.20B | 445.63M | 25.34% |
| Dec 31, 2021 | 1.76B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 81.73B |
| Alibaba Health Information Technology | 36.09B |
| YSB Inc. | 23.34B |
| Shanghai Pioneer Holding | 1.43B |
| Tycoon Group Holdings | 1.10B |
| Kingworld Medicines Group | 1.02B |
| Universal Health International Group Holding | 597.78M |
| New Ray Medicine International Holding | 130.37M |